Veritable, L.P. - SAB BIOTHERAPEUTICS INC ownership

SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 40 filers reported holding SAB BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Veritable, L.P. ownership history of SAB BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$420,406
+88.6%
506,5130.0%0.01%
+75.0%
Q1 2023$222,866
-25.4%
506,5130.0%0.00%
-20.0%
Q4 2022$298,792
+863.8%
506,513
+1063.0%
0.01%
+400.0%
Q3 2022$31,000
-50.8%
43,5510.0%0.00%0.0%
Q2 2022$63,000
-61.6%
43,5510.0%0.00%
-66.7%
Q1 2022$164,000
-51.8%
43,5510.0%0.00%
-40.0%
Q4 2021$340,00043,5510.01%
Other shareholders
SAB BIOTHERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
First PREMIER Bank 652,440$946,0000.28%
METEORA CAPITAL, LLC 292,538$424,0000.08%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 78,115$113,0000.02%
SILVER OAK SECURITIES, Inc 51,941$64,0000.01%
Shaolin Capital Management LLC 275,000$399,0000.01%
Elgethun Capital Management 13,296$18,0000.01%
LGL PARTNERS, LLC 23,000$33,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,000$122,0000.00%
Spectrum Management Group, LLC 5,030$7,0000.00%
Veritable, L.P. 43,551$63,0000.00%
View complete list of SAB BIOTHERAPEUTICS INC shareholders